Manhattan Pharmaceuticals to Webcast Annual Shareholder Meeting
May 22, 2007 10:01 ET
|
Manhattan Pharmaceuticals, Inc.
NEW YORK, May 22, 2007 (PRIME NEWSWIRE) -- Manhattan Pharmaceuticals, Inc. (AMEX:MHA) today announced it will host a live webcast of its annual shareholder meeting scheduled for Thursday, May 24, 2007...
Manhattan Pharmaceuticals to Present At Acumen/BioFin Rodman & Renshaw 4th Annual Global Healthcare Conference
May 09, 2007 08:29 ET
|
Manhattan Pharmaceuticals, Inc.
NEW YORK, May 9, 2007 (PRIME NEWSWIRE) -- Manhattan Pharmaceuticals, Inc. (AMEX:MHA) today announced that Douglas Abel, president and chief executive officer, will present at the Acumen/BioFin Rodman...
Manhattan Pharmaceuticals' Alan G. Harris, MD to Chair Drug Development for Obesity Conference
February 09, 2007 10:01 ET
|
Manhattan Pharmaceuticals, Inc.
NEW YORK, Feb. 9, 2007 (PRIME NEWSWIRE) -- Manhattan Pharmaceuticals, Inc. (AMEX:MHA) today announced that Alan G. Harris, MD, PhD, the company's Chief Medical Officer, will co-chair the upcoming...
Manhattan Receives Notification from AMEX of Non-Compliance of Certain Listing Standards
January 12, 2007 17:36 ET
|
Manhattan Pharmaceuticals, Inc.
NEW YORK, Jan. 12, 2007 (PRIME NEWSWIRE) -- Manhattan Pharmaceuticals, Inc. (AMEX:MHA) previously reported in its Form 10-QSB for the quarter ended September 30, 2006 that at September 30, 2006, the...
Manhattan Pharmaceuticals to Webcast Annual Shareholder Meeting
December 14, 2006 08:29 ET
|
Manhattan Pharmaceuticals, Inc.
NEW YORK, Dec. 14, 2006 (PRIME NEWSWIRE) -- Manhattan Pharmaceuticals, Inc. (AMEX:MHA) today announced it will host a live webcast of its annual shareholder meeting scheduled for Friday, December 15,...
Manhattan Pharmaceuticals to Present at BIO Investor Forum 2006
October 16, 2006 08:29 ET
|
Manhattan Pharmaceuticals, Inc.
NEW YORK, Oct. 16, 2006 (PRIMEZONE) -- Manhattan Pharmaceuticals, Inc. (AMEX:MHA) today announced that Douglas Abel, president and chief executive officer, will present at the BIO Investor Forum 2006...
Manhattan Pharmaceuticals' Alan G. Harris, MD, PhD to Chair Metabolic Syndrome Conference
September 19, 2006 08:29 ET
|
Manhattan Pharmaceuticals, Inc.
NEW YORK, Sept. 19, 2006 (PRIMEZONE) -- Manhattan Pharmaceuticals, Inc. (AMEX:MHA) today announced that Alan G. Harris, MD, PhD, the company's Chief Medical Officer, will chair the upcoming two-day...
Manhattan Pharmaceuticals to Present at Oppenheimer 2nd Annual Diabetes Investment Conference
September 14, 2006 08:31 ET
|
Manhattan Pharmaceuticals, Inc.
NEW YORK, Sept. 14, 2006 (PRIMEZONE) -- Manhattan Pharmaceuticals, Inc. (AMEX:MHA) today announced that Douglas Abel, president and chief executive officer, will present at the Oppenheimer 2nd Annual...
Manhattan Pharmaceuticals to Present at Merriman Curhan Ford 2006 Investor Summit
September 12, 2006 08:29 ET
|
Manhattan Pharmaceuticals, Inc.
NEW YORK, Sept. 12, 2006 (PRIMEZONE) -- Manhattan Pharmaceuticals, Inc. (AMEX:MHA) today announced that Douglas Abel, president and chief executive officer, will present at the 3rd Annual Merriman...
Manhattan Pharmaceuticals to Present at Roth Capital Partners 2006 New York Conference
August 30, 2006 08:29 ET
|
Manhattan Pharmaceuticals, Inc.
NEW YORK, Aug. 30, 2006 (PRIMEZONE) -- Manhattan Pharmaceuticals, Inc. (AMEX:MHA) today announced that Douglas Abel, president and chief executive officer of Manhattan Pharmaceuticals, Inc. will be...